| Literature DB >> 31076721 |
Xiao-Fang Yi1, Hong-Lin Xi2, Si-Lin Zhang3, Jing Yang4.
Abstract
To evaluate the relationship between the positions of cytoplasmic granulation and the oocytes developmental potential in human, we detected the developmental potentials of oocytes with centrally located cytoplasmic granulation (CLCG). The patients' age, body mass index (BMI), Infertility duration, follicle stimulation hormone (FSH) levels, average stimulate ovulation days, gonadotropin (GN) total dose, fertilization rate, cleavage rate, high quality embryo rate, embryo utilization rate and pregnancy rate were analyzed. The results showed that there were no significant difference on patients' age, BMI, infertility duration, FSH levels, average stimulate ovulation days, GN total dose, pregnancy rate and birth rate between CLCG group and control group in patients with BMI < 24 (P > 0.05). However, there was no significant difference in fertilization rate, cleavage rate, and high quality embryo rate in patients with BMI < 24 (P > 0.05). The pregnancy rate was low in both groups, but 35 and 15 healthy fetuses were born in each group. We also found that the central granulated area size did not affect fertilization rate, cleavage rate, embryo utilization rate, and high quality embryo rate (P > 0.05). These results suggested CLCG might be a normal morphology of oocyte. The oocytes from patients with or without CLCG had no significant difference in their developmental potentials. The patients who transferred CLCG embryos had successful delivery. The developmental potentials of oocytes with different CLCG grades had no obvious differences.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31076721 PMCID: PMC6510905 DOI: 10.1038/s41598-019-43757-8
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1CLGC grading of human oocytes. The central granulated area size (Scenter) and oocyte area (Soocyte) of the equatorial plane were intercepted and the Scenter/Soocyte ratio was calculated. (a) normal oocyte; (b) grade I: ratio of ≤1/4; (c) grade II: ratio of 1/4–1/2; (d) grade III: ratio of ≥1/2. Bar = 20 µM.
Clinical data of patients (BMI < 24) with CLCG oocytes and normal oocytes.
| Groups | cycles (n) | age (years) | BMI | Infertility duration (years) | Baseline FSH level (mU/mL) | GN days (day) | GN dose (IU) |
|---|---|---|---|---|---|---|---|
| Normal | 167 | 30.9 ± 4.99 | 20.45 ± 1.86 | 5.18 ± 4.14 | 7.17 ± 2.34 | 11.96 ± 3.86 | 2847.75 ± 1318.40 |
| CLCG | 88 | 29.94 ± 3.82 | 20.21 ± 1.84 | 4.26 ± 3.19 | 6.88 ± 1.87 | 11.66 ± 2.55 | 2776.99 ± 917.82 |
| 0.088 | 0.333 | 0.070 | 0.320 | 0.613 | 0.654 |
Clinical data of patients (BMI ≥ 24) with CLCG oocytes and normal oocytes.
| Groups | cycles (n) | age (years) | BMI | Infertility duration (years) | Baseline FSH level (mU/mL) | GN days (day) | GN dose (IU) |
|---|---|---|---|---|---|---|---|
| Normal | 57 | 32.51 ± 5.76 | 26.63 ± 2.68 | 5.61 ± 3.75 | 7.18 ± 2.73 | 12.67 ± 4.12 | 3249.12 ± 1288.98 |
| CLCG | 19 | 28.32 ± 5.19 | 25.75 ± 2.0 | 4.01 ± 3.44 | 6.62 ± 1.78 | 11.95 ± 2.34 | 2905.26 ± 1135.19 |
| 0.006* | 0.138 | 0.103 | 0.317 | 0.352 | 0.304 |
Pregnancy outcomes of patients (BMI < 24) with CLCG oocytes and normal oocytes.
| Groups | cycles (n) | Clinical pregnancy rate ( | Live birth rate ( | In pregnancy (n) | Abortion (n) | Ectopic pregnancy (n) |
|---|---|---|---|---|---|---|
| Normal (1) | 167 | 45 (36.29%) | 35 (28.23%) | 2 | 5 | 3 |
| CLCG (2) | 88 | 23 (38.98%) | 15 (25.42%) | 4 | 2 | 0 |
| 0.725 | 0.691 |
The effects of CLCG and normal oocytes on embryonic development potential.
| Groups | Oocytes ( | Normal fertilization rate ( | Cleavage rate ( | High quality embryo rate ( | Embryo utilization rate ( |
|---|---|---|---|---|---|
| A | 251 | 157 | 142 | 69 | 97 |
| (62.5%) | (90.4%) | (48.6%) | (68.3%) | ||
| B | 185 | 115 | 106 | 55 | 77 |
| (62.2%) | (92.2%) | (51.9%) | (72.6%) | ||
| 0.934 | 0.62 | 0.608 | 0.46 |
The effects of CLCG and normal oocytes on the pregnancy outcomes.
| Grades | Transplantation cycle (n) | pregnancy cycle (n) | Live birth (n) |
|---|---|---|---|
| Normal | 16 | 3 | 2 |
| CLCG | 15 | 5 | 5 |
The effects of Scenter/Soocyte ratio on the developmental potential of the embryo.
| Grades | Oocytes ( | Normal fertilization rate ( | Cleavage rate ( | High quality embryo rate ( | Embryo utilization rate ( |
|---|---|---|---|---|---|
| I | 79 | 47 (59.5%) | 43 (91.5%) | 17 (39.5%) | 28 (65.1%) |
| II | 86 | 56 (65.1%) | 54 (96.5%) | 34 (63.0%) | 42 (77.8%) |
| III | 20 | 12 (60.0%) | 9 (75%) | 4 (44.4%) | 7 (77.8%) |
| 0.742 | 0.042 | 0.065 | 0.357 |
The effects of Scenter/Soocyte ratio on the pregnancy outcomes.
| Grades | Transplantation cycle (n) | pregnancy cycle (n) | Live birth (n) |
|---|---|---|---|
| I | 4 | 1 | 2 |
| II | 6 | 2 | 1 |
| III | 2 | 1 | 0 |